Suraj Kalia
Stock Analyst at Oppenheimer
(3.03)
# 1,279
Out of 5,127 analysts
87
Total ratings
45.33%
Success rate
11.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Outperform | $140 → $132 | $111.07 | +18.84% | 2 | Jan 23, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $125 → $100 | $74.12 | +34.92% | 1 | Jan 16, 2026 | |
| INSP Inspire Medical Systems | Upgrades: Outperform | $175 | $66.33 | +163.83% | 3 | Dec 8, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $23 → $18 | $14.04 | +28.21% | 7 | Nov 19, 2025 | |
| EW Edwards Lifesciences | Downgrades: Perform | n/a | $76.80 | - | 6 | Oct 8, 2025 | |
| PRCT PROCEPT BioRobotics | Upgrades: Outperform | $60 | $29.21 | +105.41% | 2 | Sep 2, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $24.21 | -9.13% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $136.34 | +10.02% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $36.94 | +21.84% | 7 | Feb 13, 2025 | |
| IRTC iRhythm Holdings | Maintains: Outperform | $105 → $120 | $148.50 | -19.19% | 7 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $32 | $39.61 | -19.21% | 3 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $90 → $93 | $86.54 | +7.46% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $10 | $4.50 | +122.22% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $4.73 | +174.84% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $85.46 | +57.97% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $275.96 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $27.30 | +9.89% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $1.16 | +17,141.38% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $79.08 | +22.66% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $22.63 | +23.73% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $3.33 | +35.14% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.22 | +1,211.48% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $492.84 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $2.37 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $21.73 | +360.19% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $70.16 | - | 5 | Sep 12, 2018 |
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $140 → $132
Current: $111.07
Upside: +18.84%
Boston Scientific
Jan 16, 2026
Maintains: Outperform
Price Target: $125 → $100
Current: $74.12
Upside: +34.92%
Inspire Medical Systems
Dec 8, 2025
Upgrades: Outperform
Price Target: $175
Current: $66.33
Upside: +163.83%
Varex Imaging
Nov 19, 2025
Maintains: Outperform
Price Target: $23 → $18
Current: $14.04
Upside: +28.21%
Edwards Lifesciences
Oct 8, 2025
Downgrades: Perform
Price Target: n/a
Current: $76.80
Upside: -
PROCEPT BioRobotics
Sep 2, 2025
Upgrades: Outperform
Price Target: $60
Current: $29.21
Upside: +105.41%
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $24.21
Upside: -9.13%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $136.34
Upside: +10.02%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $36.94
Upside: +21.84%
iRhythm Holdings
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $148.50
Upside: -19.19%
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $39.61
Upside: -19.21%
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $86.54
Upside: +7.46%
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.50
Upside: +122.22%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $4.73
Upside: +174.84%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $85.46
Upside: +57.97%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $275.96
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $27.30
Upside: +9.89%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $1.16
Upside: +17,141.38%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $79.08
Upside: +22.66%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $22.63
Upside: +23.73%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $3.33
Upside: +35.14%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.22
Upside: +1,211.48%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $492.84
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $2.37
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $21.73
Upside: +360.19%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $70.16
Upside: -